Theresa Heggie Biocryst Pharmaceuticals Inc (BCRX) insider trading activity

Theresa Heggie is Director of BIOCRYST PHARMACEUTICALS INC. Currently has a direct ownership of 65,352 shares of BCRX, which is worth approximately $647,638. The most recent transaction as insider was on Jun 12, 2025, when has been sold 12,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 65.4K

23.65% 3M change

23.65% 12M change

Total Value Held $647,638

THERESA HEGGIE Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 12 2025	BUY Grant, award, or other acquisition	-	12,500 Added 16.06%	65,352 Common Stock
Jun 14 2024	SELL Open market or private sale	$40,924 $6.11 p/Share	6,698 Reduced 11.25%	52,852 Common Stock
Jun 12 2024	BUY Grant, award, or other acquisition	-	6,820 Added 10.28%	59,550 Common Stock
May 31 2024	BUY Grant, award, or other acquisition	$5,620 $6.46 p/Share	870 Added 1.62%	52,730 Common Stock
Feb 29 2024	BUY Grant, award, or other acquisition	$5,624 $5.63 p/Share	999 Added 1.89%	51,860 Common Stock
Nov 30 2023	BUY Grant, award, or other acquisition	$5,621 $5.88 p/Share	956 Added 1.84%	50,861 Common Stock
Aug 31 2023	BUY Grant, award, or other acquisition	$5,624 $7.11 p/Share	791 Added 1.56%	49,905 Common Stock
Jun 13 2023	BUY Grant, award, or other acquisition	-	16,745 Added 25.43%	49,114 Common Stock
May 31 2023	BUY Grant, award, or other acquisition	$5,623 $8.27 p/Share	680 Added 2.06%	32,369 Common Stock
Feb 28 2023	BUY Grant, award, or other acquisition	$5,619 $8.85 p/Share	635 Added 1.96%	31,689 Common Stock
Nov 30 2022	BUY Grant, award, or other acquisition	$5,624 $13.36 p/Share	421 Added 1.34%	31,054 Common Stock
Aug 31 2022	BUY Grant, award, or other acquisition	$5,616 $13.9 p/Share	404 Added 1.3%	30,633 Common Stock
Jun 07 2022	BUY Grant, award, or other acquisition	-	12,866 Added 29.85%	30,229 Common Stock
May 31 2022	BUY Grant, award, or other acquisition	$10,595 $9.31 p/Share	1,138 Added 6.15%	17,363 Common Stock
Feb 28 2022	BUY Grant, award, or other acquisition	$9,999 $16.61 p/Share	602 Added 3.58%	16,225 Common Stock
Nov 30 2021	BUY Grant, award, or other acquisition	$9,998 $12.06 p/Share	829 Added 5.04%	15,623 Common Stock
Aug 31 2021	BUY Grant, award, or other acquisition	$9,998 $15.92 p/Share	628 Added 4.07%	14,794 Common Stock
May 28 2021	BUY Grant, award, or other acquisition	$4,999 $15.77 p/Share	317 Added 2.19%	14,166 Common Stock
Feb 26 2021	BUY Grant, award, or other acquisition	$4,991 $10.78 p/Share	463 Added 3.24%	13,849 Common Stock
Nov 30 2020	BUY Grant, award, or other acquisition	$4,998 $5.11 p/Share	978 Added 6.81%	13,386 Common Stock

Theresa Heggie

Director

Durham, NC

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BCRX shares.

Notify only if

Value

Insider Trading

Get notified when an Biocryst Pharmaceuticals Inc insider buys or sells BCRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to BIOCRYST PHARMACEUTICALS INC

Track Activities on BCRX

Account